Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments. [electronic resource]
Producer: 20120612Description: 192-5 p. digitalISSN:- 1532-2130
- Adrenocorticotropic Hormone -- therapeutic use
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Ataxia -- drug therapy
- Child Behavior Disorders -- etiology
- Dexamethasone -- therapeutic use
- Drug Resistance
- Electroencephalography
- Gait Disorders, Neurologic -- drug therapy
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Infant
- Magnetic Resonance Imaging
- Male
- Opsoclonus-Myoclonus Syndrome -- drug therapy
- Prednisone -- therapeutic use
- Rituximab
- Speech Disorders -- drug therapy
- Treatment Outcome
- Tremor -- drug therapy
- Virus Diseases -- complications
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.